Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: May 15, 2023
Reporting Period: The filing references financial results for the three months ended March 31, 2023, and a press release dated May 15, 2023.
Key Financial Metrics
The provided text is a cover sheet for Form 6-K and does not contain specific financial data. It references attached exhibits (99.1 and 99.2) which contain the press release and financial results, but the numerical values for revenue, profit, cash flow, margins, debt, and liquidity are not present in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only indicates that financial results for the quarter ended March 31, 2023, were posted to the company website and attached as an exhibit.
Guidance, Outlook, and Risks
The text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in the attached exhibits is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 15, 2023) for qualitative updates and strategic announcements.
- Review Exhibit 99.2 (Financial Results for the three months ended March 31, 2023) for specific revenue, profit, and cash flow figures.
- Verify the company's website for the full financial report referenced in the filing.
- Note that the attached exhibits are furnished, not filed, under Section 18 of the Exchange Act.